相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Aurora kinase inhibitor ZM447439 induces apoptosis via mitochondrial pathways
Minglun Li et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Discovery of Atg5/Atg7-independent alternative macroautophagy
Yuya Nishida et al.
NATURE (2009)
Inactivation of CDK2 is synthetically lethal to MYCN over-expressing cancer cells
Jan J. Molenaar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis
Kirsteen H. Maclean et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Adenovirus E1A targets p400 to induce the cellular oncoprotein Myc
Kathryn A. Tworkowski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Limiting the proliferation of polyploid cells
Neil J. Ganem et al.
CELL (2007)
Autophagosome formation: Core machinery and adaptations
Zhiping Xie et al.
NATURE CELL BIOLOGY (2007)
Chromosomal passengers: conducting cell division
Sandrine Ruchaud et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Non-transcriptional control of DNA replication by c-Myc
David Dominguez-Sola et al.
NATURE (2007)
Inhibition of CDK1 as a potential therapy for tumors over-expressing MYC
Andrei Goga et al.
NATURE MEDICINE (2007)
Discovery, synthesis, and in vivo activity of a new class of pyrazoloquinazolines as selective inhibitors of aurora B kinase
Andrew A. Mortlock et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma
Andrew P. Weng et al.
GENES & DEVELOPMENT (2006)
The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function
Farid Gizatullin et al.
CANCER RESEARCH (2006)
Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants
MT Hemann et al.
NATURE (2005)
Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases
TA Carter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo
EA Harrington et al.
NATURE MEDICINE (2004)
Acute ablation of survivin uncovers p53-dependent mitotic checkpoint functions and control of mitochondrial apoptosis
E Beltrami et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The role of autophagy during the early neonatal starvation period
A Kuma et al.
NATURE (2004)
Cell division and cell survival in the absence of survivin
D Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Synthetic lethal targeting of MYC by activation of the DR5 death receptor pathway
Y Wang et al.
CANCER CELL (2004)
Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores
C Ditchfield et al.
JOURNAL OF CELL BIOLOGY (2003)
Myc suppression of the p21Cip1 Cdk inhibitor influences the outcome of the p53 response to DNA damage
J Seoane et al.
NATURE (2002)
c-MYC: More than just a matter of life and death
S Pelengaris et al.
NATURE REVIEWS CANCER (2002)
c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: A mechanism for oncogene-induced genetic instability
O Vafa et al.
MOLECULAR CELL (2002)
Apoptosis: A link between cancer genetics and chemotherapy
RW Johnstone et al.
CELL (2002)
Overexpression of c-Myc alters G(1)/S arrest following ionizing radiation
JH Sheen et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
分享论文
